A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)
NCT07011043
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Systemic Lupus Erythematosus
Interventions
DRUG:
Budoprutug
Sponsor
Climb Bio, Inc.